Exenatide/Glucagon Agonist (Prolynx)

N/A

Report date: 2025/01/26 17:02:53

Base Information

Drug NameExenatide/Glucagon Agonist (Prolynx)
Drug Alias NamePeptidic Dual-Agonist (Prolynx)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucagon receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucagon receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProlynx Llc
China Registration ClassN/A

Develop Information

Active CompaniesProlynx Llc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A